| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w28545 |
| 来源ID | Working Paper 28545 |
| Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool | |
| Alberto Galasso; Mark Schankerman | |
| 发表日期 | 2021-03-15 |
| 出版年 | 2021 |
| 语种 | 英语 |
| 摘要 | We study the effects of an institution that pools patents across geographical markets on the licensing and adoption of life-saving drugs in low- and middle-income countries. Using data on licensing and sales for HIV, hepatitis C and tuberculosis drugs, we show that there is an immediate and large increase in licensing by generic firms when a patent is included in the Medicines Patent Pool (MPP). The effect is heterogeneous across countries. The findings are robust to identification strategies to deal with endogeneity of MPP patents and countries. The impact on actual entry and sales, however, is much smaller than on licensing, which is due to geographic bundling of licenses by the MPP. More broadly, the paper highlights the potential of pools in promoting technology diffusion in developing countries. |
| 主题 | Health, Education, and Welfare ; Health ; Development and Growth ; Innovation and R& ; D |
| URL | https://www.nber.org/papers/w28545 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/586217 |
| 推荐引用方式 GB/T 7714 | Alberto Galasso,Mark Schankerman. Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool. 2021. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w28545.pdf（352KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
